https://www.taxtmi.com/caselaws?id=93608 For excise classification, a medicament is treated as Ayurvedic only if it is manufactured exclusively in accordance with formulae in authoritative Ayurvedic texts. Stamifort Supreme Capsules failed that test because it contained a Unani ingredient, was not made solely from an Ayurvedic text-based formula, and was developed as a proprietary brand product. FDA approval for marketing as an Ayurvedic medicine was insufficient to override the statutory requirement. The product was therefore classified as a patent and proprietary medicament, and the prior classification as an Ayurvedic medicament was set aside. en-us Thu, 25 May 2000 00:00:00 +0530 Mon, 14 Nov 2011 16:15:14 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=93608 For excise classification, a medicament is treated as Ayurvedic only if it is manufactured exclusively in accordance with formulae in authoritative Ayurvedic texts. Stamifort Supreme Capsules failed that test because it contained a Unani ingredient, was not made solely from an Ayurvedic text-based formula, and was developed as a proprietary brand product. FDA approval for marketing as an Ayurvedic medicine was insufficient to override the statutory requirement. The product was therefore classified as a patent and proprietary medicament, and the prior classification as an Ayurvedic medicament was set aside. Case-Laws Central Excise Thu, 25 May 2000 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=93608